In this 15-minute podcast, Sakir Mutevelic, MD, MSc, Curium’s chief medical officer, discusses the ECLIPSE trial in greater detail, including eligibility criteria and how to enroll patients. In addition, he describes the role of radiopharmaceuticals in diagnosing and treating prostate cancer and a patient’s typical diagnostic journey.